MITOMYCINE SUBSTIPHARM 20 mg, powder for solution for injection/infusion or route intravesical bottle, 50 ml
Active ingredients: MITOMYCINE C
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusionbottle, 50 mlintraartérielle;intraséreuse;intraveineuse;intravésicale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MITOMYCINE SUBSTIPHARM 20 mg, poudre pour solution injectable/perfusion ou voie intravésicale
- Pharmaceutical form
- poudre pour solution injectable pour perfusion ou
- Route of administration
- intraartérielle;intraséreuse;intraveineuse;intravésicale
- Presentation description
- 1 flacon en verre jaune(brun) de 50 ml avec 1 filtre stérile à usage unique poly(fluorure de vinylidène) (PVDF)
- Marketing authorisation holder
- SUBSTIPHARM
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Apr 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63017696CIP73018651CIP133400930186510Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MITOMYCINE Cpoudre | 20 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.